Advanced search
Publication Cover
Leukemia & Lymphoma Volume 22, 1996 - Issue sup1
Submit an article Journal homepage
47
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Treatment Strategies in Essential Thrombocythemia a critical appraisal of various experiences in different centers

Tiziano Barbui Division of Hematology, Ospedali Riuniti Bergamo, Italy
,
Guido Finazzi Division of Hematology, Ospedali Riuniti Bergamo, Italy
,
Evelyne Dupuy Service d'angiohématologie clinique, Hôpital Lariboisière, Paris, Cedex
,
Jean-Jacques Kiladjian Division of Hematology, Beaujon Hospital, Clichy, France
&
Jean Brière Division of Hematology, Beaujon Hospital, Clichy, France
Pages 149-160 | Received 18 Mar 1996, Published online: 01 Jul 2009

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

John T. Reilly. (2012) Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists. Hematology 17:4, pages 187-192.
Read now
Apostolia-Maria Tsimberidou & Francis J. Giles. (2002) Essential Thrombocythemia (ET): Moving from Palliation to Cure. Hematology 7:6, pages 315-323.
Read now
S. Killick, E. Matutes, J. Swansbury & D. Catovsky. (1998) Case 17: Essential Thrombocythaemia with Inversion 3 Terminating in Acute Leukaemia. Leukemia & Lymphoma 30:5-6, pages 661-665.
Read now
Tiziano Barbui, Guido Finazzi & Thomas C. Pearson. (1997) The Management of Essential Thrombocythaemia. Hematology 2:2, pages 91-100.
Read now

Articles from other publishers (31)

Christina S. Han, Michael J. Paidas & Charles J. Lockwood. 2011. High Risk Pregnancy. High Risk Pregnancy 739 752.e5 .
Young Mi SeolBo Ran KwonYoung Jin ChoiKyung Woo LeeHo Jin ShinJoo Seop ChungEun Yup LeeWon Sik LeeYoung Don JooGoon Jae Cho. (2008) The Efficacy and Adverse Effect of Hydroxyurea as Compared with Anagrelide in Essential Thrombocythemia. The Korean Journal of Hematology 43:2, pages 83.
Crossref
Jean B Brière. (2007) Essential thrombocythemia. Orphanet Journal of Rare Diseases 2:1.
Crossref
Roeland P. M. Ceulen, Jorge Frank & Pamela Poblete-Gutiérrez. (2007) Nail pigmentation due to hydroxycarbamide. International Journal of Dermatology 46:s3, pages 13-15.
Crossref
O. Messouak, M. Alaoui Faris, M. Benabdejlil, S. Tizniti & F. Belahsen. (2007) Thrombose veineuse cérébrale secondaire à une thrombocytémie essentielle. Revue Neurologique 163:5, pages 596-598.
Crossref
Sylvia Bellucci. (2007) Manifestations vasculaires au cours des thrombocytémies essentielles. Bulletin de l'Académie Nationale de Médecine 191:3, pages 519-533.
Crossref
Elisabeth I Penninga & Ole W Bjerrum. (2006) Polycythaemia Vera and Essential Thrombocythaemia. Drugs 66:17, pages 2173-2187.
Crossref
J. Brière. (2006) Thrombocytémie essentielle. Critères du diagnostic. Stratification pronostique. Ébauche de stratégie thérapeutique. EMC - Hématologie 1:3, pages 1-19.
Crossref
Rashid Saba, Elias Jabbour, Francis Giles, Jorge Cortes, Moshe Talpaz, Susan O'Brien, Emil J. Freireich, Guillermo Garcia‐Manero, Hagop Kantarjian & Srdan Verstovsek. (2005) Interferon α therapy for patients with essential thrombocythemia. Cancer 103:12, pages 2551-2557.
Crossref
Steven M. Fruchtman, Robert M. Petitt, Harriet S. Gilbert, Garrick Fiddler & Andrew Lyne. (2005) Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders. Leukemia Research 29:5, pages 481-491.
Crossref
Masanori Umeda, Kimiko Iijima, Chiaki Arai & Masako Katoh. (2004) Therapeutic effectiveness of ranimustine chemotherapy for elderly essential thrombocythemia*. Geriatrics and Gerontology International 4:4, pages 223-228.
Crossref
Michael Steurer, Guenther Gastl, Wieslaw‐Wiktor Jedrzejczak, Robert Pytlik, Werner Lin, Ernst Schlögl & Heinz Gisslinger. (2004) Anagrelide for thrombocytosis in myeloproliferative disorders. Cancer 101:10, pages 2239-2246.
Crossref
Lee-Yung ShihTung-Liang LinChang-Liang LaiPo DunnJin-Hou WuPo-Nan WangMing-Chung KuoLai-Chu Lee. (2002) Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia. Blood 100:5, pages 1596-1601.
Crossref
Tiziano Barbui. (2002) What is the standard treatment in essential thrombocythemia. International Journal of Hematology 76:S2, pages 311-317.
Crossref
J Briere & F Guilmin. (2001) Management of patients with essential thrombocythemia: current concepts and perspectives. Pathologie Biologie 49:2, pages 178-183.
Crossref
G Finazzi & T Barbui. (2001) Efficacy and safety of hydroxyurea in patients with essential thrombocythemia. Pathologie Biologie 49:2, pages 167-169.
Crossref
S.N Tsiara, L Christou, K Panteli, D Anastasopoulos & K.L Bourantas. (2000) A patient with essential thrombocytosis and multiple sclerosis. European Journal of Internal Medicine 11:6, pages 345-347.
Crossref
Giancarlo Liumbruno, Paolo Emilio Centoni, Silvia Ceretelli & Maria Laura Sodini. (2001) Rapid Reduction of Platelet Numbers in Thrombocytosis. Therapeutic Apheresis 4:5, pages 374-376.
Crossref
Berrebi Alain, Shvidel Lev, Shtalrid Mordechai & Klepfish Abraham. (2000) SHORT COURSE OF BUSULphAN IN ESSENTIAL THROMBOCYTHaEMIA: REMODELlING OF AN OLD STRATEGY. British Journal of Haematology 109:1, pages 249-250.
Crossref
Jan Jacques Michiels. (2016) Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia. Clinical and Applied Thrombosis/Hemostasis 5:4, pages 247-251.
Crossref
Dawson, Slater, Hagemeijer, Langerak, Willemze & Kluin‐Nelemans. (2001) Secondary T‐acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia. British Journal of Haematology 106:1, pages 104-106.
Crossref
Owe Lannemyr & Jack Kutti. (2009) Hydroxyurea as a cause of drug fever in essential thrombocythaemia. European Journal of Haematology 62:5, pages 354-355.
Crossref
Heinz Gisslinger, Francesco Rodeghiero, Marco Ruggeri, Navide Heis‐Vahidi Fard, Christine Mannhalter, Menelaos Papagiannopoulos, Claudia Rintelen, Wolfgang Lalouschek, Paul Knöbl, Klaus Lechner & Ingrid Pabinger. (2005) Homocysteine levels in polycythaemia vera and essential thrombocythaemia. British Journal of Haematology 105:2, pages 551-555.
Crossref
S. Bellucci, C. Legrand, B. Boval, L. Drouet & J. Caen. (2001) Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide. British Journal of Haematology 104:4, pages 886-892.
Crossref
A. K. Mills, K. M. Taylor, S. J. Wright, I. Bunce, P. Eliadis, M. C. Brigden, G. Seeley, J. Bashford, T. Olsen, A. Rentoul & C. Kelly. (2008) Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemia. Australian and New Zealand Journal of Medicine 29:1, pages 29-35.
Crossref
Stephen D. Nimer. (1999) Essential Thrombocythemia: Another “Heterogeneous Disease” Better Understood?. Blood 93:2, pages 415-416.
Crossref
Ruggeri, Finazzi, Tosetto, Riva, Rodeghiero & Barbui. (2002) No treatment for low‐risk thrombocythaemia:results from a prospective study. British Journal of Haematology 103:3, pages 772-777.
Crossref
Herwig Lackner, Christian Urban, Christine Beham-Schmid, Martin Benesch, Reinhold Kerbl & Wolfgang Schwinger. (1998) Treatment of Children With Anagrelide for Thrombocythemia. Journal of Pediatric Hematology/Oncology 20:5, pages 469-473.
Crossref
S. Willoughby & T.C. Pearson. (1998) The use of aspirin in polycythaemia vera and primary thrombocythaemia. Blood Reviews 12:1, pages 12-22.
Crossref
Yvon SterkersClaude PreudhommeJean-Luc Laı̈Jean-Loup DemoryMarie-Thérèse CaulierEric WattelDominique BordessouleFrancis BautersPierre Fenaux. (1998) Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion. Blood 91:2, pages 616-622.
Crossref
Jean Briere, Jean-Jacques Kiladjian & Edith Peynaud-Debayle. (1997) 4 Megakaryocytes and platelets in myeloproliferative disorders. Baillière's Clinical Haematology 10:1, pages 65-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.